Resources

InCrowd Survey: NASH-Treating Physician Perspectives

See the more-recent, 2019 NASH Report

InCrowd conducted 30-minute MicroQual interviews with four physicians considered key opinion leaders on Non-alcoholic Steatohepatitis (NASH). Then used this feedback to develop a 5-minute quantitative MicroSurvey for 55 gastroentologists and hepatologists.

Research Objectives:

  • Determine physician interests in and perspectives on NASH treatments in development.

  • Gauge the prevalence of comorbid conditions that require physician management alongside NASH and understand which physician specialties are ultimately stakeholders in patient care.

Methodology:
Method: 5-minute MicroSurvey via InCrowd
Crowds: US Gastroenterologists, Hepatologists
Sample Size: n=55
Fielding Period: April 25-26, 2018

One key insight: physicians feel that any effective treatment for NASH will need to be a combination regimen, versus a single agent, that helps resolve liver fibrosis, reduce liver inflammation, and interrupt the storage of fat in the liver.

Download the full report now!

Please fill out the form below to access this content

Name(Required)
Consent
This field is for validation purposes and should be left unchanged.

Related Resources

The Impact of Technology on Mental Healthcare

The Impact of Technology on Mental Healthcare

Exploring Psychiatrist Opinions and Expectations Around the Rise in Digital Therapeutics to Treat Mental Health The National Institutes of Health (NIH) believe “technology has opened a new frontier in mental health support,” but questions remain around how...

read more
ESMO 2022 Real-Time Roundup

ESMO 2022 Real-Time Roundup

The 2022 Annual Meeting of the European Society for Medical Oncology (ESMO) took place in person from September 9th to the 13th. InCrowd wanted to learn from those Medical Oncologists and Hematology-Oncologists who attended the following two objectives: Explore which...

read more
ASCO 2022 Real-Time Roundup

ASCO 2022 Real-Time Roundup

The 2022 Annual Meeting of the American Society of Clinical Oncology (ASCO) took place in person from June 3rd to the 7th. InCrowd wanted to learn from those oncologists who attended the following two objectives: Explore which tumor type/track had the most exciting...

read more